Integral Diagnostics Limited

ASX IDX.AX

Integral Diagnostics Limited Gross Profit for the year ending June 30, 2024: USD 297.89 M

Integral Diagnostics Limited Gross Profit is USD 297.89 M for the year ending June 30, 2024, a 357.87% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Integral Diagnostics Limited Gross Profit for the year ending June 30, 2023 was USD 65.06 M, a 12.44% change year over year.
Integral Diagnostics Limited Gross Profit for the year ending June 30, 2022 was USD 57.86 M, a -16.29% change year over year.
Integral Diagnostics Limited Gross Profit for the year ending June 30, 2021 was USD 69.12 M, a 38.95% change year over year.
Integral Diagnostics Limited Gross Profit for the year ending June 30, 2020 was USD 49.75 M, a -22.13% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

ASX: IDX.AX

Integral Diagnostics Limited

CEO	Dr. Ian Kadish M.B.A., MBBCh
IPO Date	Oct. 20, 2015
Location	Australia
Headquarters	45 William Street
Employees	1,977
Sector	Health Care
Industries Hospitals & Clinics Medical Instruments Professional Services Telehealth

Description

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Key trends

Past 5 years